Microbial Engraftment and Efficacy of Fecal Microbiota Transplant for Clostridium Difficile in Patients With and Without Inflammatory Bowel Disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Microbial Engraftment and Efficacy of Fecal Microbiota Transplant for Clostridium Difficile in Patients With and Without Inflammatory Bowel Disease

Published:2019-03-10 Issue:6 Volume:25 Page:969-979
ISSN:1078-0998
Container-title:Inflammatory Bowel Diseases
language:en
Short-container-title:

Author:

Hirten Robert P¹,Grinspan Ari¹,Fu Shih-Chen²,Luo Yuying¹,Suarez-Farinas Mayte²³,Rowland John³,Contijoch Eduardo J²,Mogno Ilaria²,Yang Nancy¹,Luong Tramy²,Labrias Philippe R²,Peter Inga²,Cho Judy H²,Sands Bruce E¹,Colombel Jean Frederic¹,Faith Jeremiah J²⁴,Clemente Jose C²⁴

Affiliation:

1. The Dr. Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, NY, USA

2. Icahn Institute for Genomics & Multiscale Biology, Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York NY, USA

3. Center for Biostatistics, Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, NY, USA

4. Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York NY, USA

Funder

Crohn’s and Colitis Foundation of America

George Waechter Memorial Foundation

National Institutes of Health

National Institute of Diabetes and Digestive and Kidney Diseases

Publisher

Oxford University Press (OUP)

Subject

Gastroenterology,Immunology and Allergy

Link

http://academic.oup.com/ibdjournal/article-pdf/25/6/969/28559497/izy398.pdf

Reference31 articles.

1. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA);Cohen;Infect Control Hosp Epidemiol.,2010

2. Recurrent clostridium difficile disease: epidemiology and clinical characteristics;McFarland;Infect Control Hosp Epidemiol.,1999

3. Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections;Surawicz;Am J Gastroenterol.,2013

4. Recurrence of Clostridium difficile infection in patients with inflammatory bowel disease: the RECIDIVISM study;Razik;Am J Gastroenterol.,2016

5. Recovery of the gut microbiome following fecal microbiota transplantation;Seekatz;Mbio.,2014

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Microbiome modification for personalized treatment of dysbiotic diseases;Cell Host & Microbe;2024-08

2. Comparative Efficacy of Fecal Microbiota Transplantation in Treating Refractory or Recurrent Clostridioides difficile Infection among Patients with and without Inflammatory Bowel Disease: A Retrospective Cohort Study;Biomedicines;2024-06-23

3. The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridioides difficile infection and other potential indications: second edition of joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines;Journal of Hospital Infection;2024-06

4. The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridioides difficile infection and other potential indications: second edition of joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines;Gut;2024-04-12

5. Vitexin-rhamnoside encapsulated with zein-pectin nanoparticles relieved high-fat diet induced lipid metabolism disorders in mice by altering the gut microbiota;International Journal of Biological Macromolecules;2024-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3